Ishani Savant Landry Ph.D holds extensive experience in clinical pharmacology and drug metabolism and pharmacokinetics (DMPK), currently serving as Vice President at Alkermes since March 2022. Prior roles include Senior Director and Director positions in Clinical Pharmacology and Translational Medicine at Eisai US from February 2016 to March 2022, and Associate Director at Bristol-Myers Squibb, focusing on virology and neuroscience. Earlier experience includes managerial and scientific roles at Celgene Corporation, Schering Plough Research Institute, Globomax, and Alpharma Pharmaceuticals. Ishani Savant Landry holds a Ph.D. in Pharmacokinetics from Long Island University and a B.Pharm in Pharmacy from SNDT University.
This person is not in any offices